hydroxychloroquine has been researched along with Retinitis in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Retinitis: Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HJ | 1 |
| Kim, SJ | 1 |
| Maksymowych, W | 1 |
| Russell, AS | 1 |
| Bertrand, JJ | 1 |
| Debeyre, N | 1 |
| Kahn, MF | 1 |
| Ryckewaert, A | 1 |
| Carr, RE | 1 |
| Henkind, P | 1 |
| Rothfield, N | 1 |
| Siegel, IM | 1 |
1 review available for hydroxychloroquine and Retinitis
| Article | Year |
|---|---|
Antimalarials in rheumatology: efficacy and safety.
Topics: Antimalarials; Arthritis, Rheumatoid; Biomechanical Phenomena; Chloroquine; Clinical Trials as Topic | 1987 |
1 trial available for hydroxychloroquine and Retinitis
| Article | Year |
|---|---|
Antimalarials in rheumatology: efficacy and safety.
Topics: Antimalarials; Arthritis, Rheumatoid; Biomechanical Phenomena; Chloroquine; Clinical Trials as Topic | 1987 |
3 other studies available for hydroxychloroquine and Retinitis
| Article | Year |
|---|---|
Sudden visual loss in a patient with systemic lupus erythematosus caused by a combination of the disease itself and drug toxicity.
Topics: Blindness; Cataract Extraction; Female; Fluorescein Angiography; Humans; Hydroxychloroquine; Lupus E | 2020 |
[Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
Topics: Antimalarials; Chloroquine; Corneal Opacity; Drug Tolerance; Electroretinography; Eye Diseases; Hydr | 1968 |
Ocular toxicity of antimalarial drugs. Long-term follow-up.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Electrooculography; Electror | 1968 |